Today, the Hong Kong stock market continued to rebound. As of 13:33, HePlatinum Pharmaceutical-B led the way up 8.11%, Shanjian Technology rose 7.80%, Zai Lab Limited-SB rose 6.96%, Federal Pharmaceutical rose 6.37%, and Aikang Medical rose 6.14%. Hang Seng Medical ETF (513060) rose 0.88% in intraday trading, recording two Lianyang, with a turnover of 87.75 million, a turnover rate of 15.90%, and highly active trading.

Shen Wanhongyuan Securities said that under the influence of policies such as health insurance negotiations and volume procurement, great changes have taken place within the health care industry, and the "new economy" represented by innovative drugs, Internet medical care, innovative devices, CXO, and characteristic medical services is expected to achieve better development.

Shenwan Hongyuan Securities also said that the cumulative return of the Hang Seng Healthcare Index in the past three years reached 41.12%, significantly ahead of the Shanghai and Shenzhen 300 and the Hang Seng Composite Index over the same period. The valuation level of the index is currently at an all-time low in nearly a year, and the bargain-hunting layout can be found in the current macro environment.